EntryPoint Capital LLC Increases Holdings in Varex Imaging Co. (NASDAQ:VREX)

EntryPoint Capital LLC increased its position in shares of Varex Imaging Co. (NASDAQ:VREX) by 39.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 43,232 shares of the company’s stock after purchasing an additional 12,285 shares during the quarter. EntryPoint Capital LLC’s holdings in Varex Imaging were worth $631,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of VREX. Wellington Management Group LLP purchased a new stake in shares of Varex Imaging in the 3rd quarter valued at $19,801,000. Wealthfront Advisers LLC acquired a new position in Varex Imaging during the fourth quarter valued at $18,900,000. Geode Capital Management LLC boosted its holdings in Varex Imaging by 0.5% in the third quarter. Geode Capital Management LLC now owns 929,004 shares of the company’s stock valued at $11,076,000 after purchasing an additional 4,211 shares during the last quarter. Royce & Associates LP grew its position in Varex Imaging by 70.4% during the 4th quarter. Royce & Associates LP now owns 746,770 shares of the company’s stock worth $10,895,000 after purchasing an additional 308,629 shares during the period. Finally, Boston Partners purchased a new position in shares of Varex Imaging during the 4th quarter valued at about $8,718,000.

Insider Buying and Selling

In related news, SVP Kimberley E. Honeysett sold 4,007 shares of Varex Imaging stock in a transaction dated Thursday, March 20th. The stock was sold at an average price of $12.81, for a total value of $51,329.67. Following the sale, the senior vice president now directly owns 4,002 shares in the company, valued at approximately $51,265.62. The trade was a 50.03 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. 4.30% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Oppenheimer lowered their target price on Varex Imaging from $30.00 to $23.00 and set an “outperform” rating on the stock in a research note on Friday, February 7th. StockNews.com raised shares of Varex Imaging from a “hold” rating to a “buy” rating in a research note on Friday, February 7th. Finally, B. Riley reiterated a “buy” rating and issued a $22.00 target price (up from $21.00) on shares of Varex Imaging in a research note on Friday, February 7th.

Varex Imaging Trading Down 1.0 %

VREX stock opened at $12.45 on Tuesday. The company has a quick ratio of 2.50, a current ratio of 4.36 and a debt-to-equity ratio of 1.02. Varex Imaging Co. has a 52-week low of $10.19 and a 52-week high of $18.30. The company’s 50-day simple moving average is $13.26 and its 200-day simple moving average is $13.44. The firm has a market cap of $512.94 million, a P/E ratio of -10.64 and a beta of 0.56.

Varex Imaging (NASDAQ:VREX) last issued its quarterly earnings data on Thursday, February 6th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.04 by $0.03. Varex Imaging had a positive return on equity of 4.00% and a negative net margin of 5.79%. As a group, equities analysts forecast that Varex Imaging Co. will post 0.53 EPS for the current fiscal year.

Varex Imaging Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.